North America Asthma Spacers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Aerochamber, Optichamber, Volumatic, and Inspirease) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce)

The asthma spacers market in North America is expected to grow from US$ 753.08 million in 2022 to US$ 1,035.10 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2022 to 2028.  

The rising usage of metered dose inhalers is the major factor driving the growth of the North America asthma spacers market. The extensively increasing prevalence of respiratory conditions, such as asthma and COPD, creates lucrative opportunities to adopt metered-dose inhalers. For instance, according to a study published by a group of researchers at the Department of Pulmonary and Critical Care Medicine, Mayo Clinic, in 2020, the number of asthma cases is expected to reach nearly 52.0% in the next 20 years in the US. Furthermore, according to the same study, the spending for the treatment of asthma in the US is expected to reach US$ 963 billion by 2038, which is expected to drive the uptake of metered-dose inhalers, eventually accelerating the adoption of inhalers and spacers during the forecast period.  

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America asthma spacers market. The North America asthma spacers market  is expected to grow at a good CAGR during the forecast period.

 North America Asthma Spacers Market Revenue and Forecast to 2028 (US$ Million)

North America Asthma Spacers Market Segmentation

North America asthma spacers market is segmented into product, distribution channel, and country. Based on product, the Asia Pacific asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. In 2022, the aerochamber is expected to hold the largest market share and is expected to witness the highest CAGR from 2022 to 2028. Based on distribution channel, the Asia Pacific asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and E-commerce. The retail pharmacy segment is expected to hold the largest share of the market in 2022. Based on country, the North America asthma spacers market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022.  

Agaplastic, Cipla Inc., Koninklijke Philips N.V., Koo Medical Equipment, Laboratoire ProtecSom, Lupin, Metall Zug, Monaghan Medical Corporation, PARI GmbH, and Teleflex Incorporated are among the leading companies in the asthma spacers market in the region.

1. Agaplastic
2. Cipla Inc.
3. Koninklijke Philips N.V.
4. Koo Medical Equipment
5. Laboratoire ProtecSom
6. Lupin
7. Metall Zug
8. Monaghan Medical Corporation
9. PARI GmbH
10. Teleflex Incorporated

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America asthma spacers market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the North America asthma spacers market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the asthma spacers market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution